Swiss National Bank - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 81 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 6.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2016$174,000
-34.8%
31,500
+22.6%
0.00%
-100.0%
Q4 2015$267,000
-43.8%
25,7000.0%0.00%0.0%
Q3 2015$475,000
+11.0%
25,700
+16.8%
0.00%0.0%
Q2 2015$428,000
+10.6%
22,0000.0%0.00%0.0%
Q1 2015$387,000
+9.9%
22,0000.0%0.00%0.0%
Q4 2014$352,000
+27.1%
22,0000.0%0.00%0.0%
Q3 2014$277,000
-19.5%
22,0000.0%0.00%0.0%
Q2 2014$344,000
+68.6%
22,000
+41.9%
0.00%0.0%
Q1 2014$204,000
+15.3%
15,500
+40.9%
0.00%0.0%
Q4 2013$177,000
-44.9%
11,000
-43.0%
0.00%0.0%
Q3 2013$321,000
+57.4%
19,300
-4.9%
0.00%0.0%
Q2 2013$204,00020,3000.00%
Other shareholders
OSIRIS THERAPEUTICS INC NEW shareholders Q1 2016
NameSharesValueWeighting ↓
Venator Capital Management Ltd. 218,300$4,248,0003.89%
Consonance Capital Management LP 1,176,195$22,889,0002.30%
RATIONAL ADVISORS LLC 64,000$1,245,0000.40%
PRINCETON CAPITAL MANAGEMENT INC 34,825$678,0000.36%
TURNER INVESTMENTS LLC 91,500$1,780,0000.33%
FALCON POINT CAPITAL, LLC 26,596$518,0000.18%
Freedom Investment Management, Inc. 76,469$1,488,0000.15%
Baker Brothers Advisors 499,193$9,714,0000.08%
Spark Investment Management LLC 27,600$536,0000.08%
OXFORD ASSET MANAGEMENT LLP 128,247$2,496,0000.07%
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders